| Expression pattern: |
UP |
| Associated gene: |
MUC19 |
| Associated microRNA: |
miR-593 |
| Biological function: |
hsa_circ_0007534 acts as an oncogene in breast cancer; knockdown inhibits BC cell proliferation, viability, colony formation and invasion, promotes apoptosis, and induces G1 phase accumulation with reduced S and G2/M phases. |
| Molecular mechanism: |
hsa_circ_0007534 functions as a miR-593 sponge, negatively regulates miR-593, and promotes MUC19 expression through the hsa_circ_0007534/miR-593/MUC19 regulatory loop. |
| Biological pathway or process: |
ceRNA regulation (promotes); proliferation (promotes); invasion (promotes); apoptosis (inhibits); cell cycle (promotes) |
| Detected method: |
Q
|
| Validation methods: |
Sanger Sequencing; RT-qPCR; Clinical Sample Validation; Bioinformatics Analysis; Transfection; CCK8; Colony Formation Assay; Transwell Assay; Annexin V/PI Flow Cytometry; Cell Cycle Assay; Luciferase Reporter Assay; circRIP; Western Blot |
| Clinical significance: |
hsa_circ_0007534 is significantly upregulated in BC tissues and may have an oncogenic role and therapeutic relevance in BC. |
| Description: |
hsa_circ_0007534 is upregulated in breast cancer tissues and cell lines and functions as an oncogenic circRNA. Its knockdown suppresses BC cell viability, proliferation, colony formation and invasion, promotes apoptosis, and alters cell-cycle distribution. Mechanistically, hsa_circ_0007534 sponges miR-593 to relieve repression of MUC19, forming a hsa_circ_0007534/miR-593/MUC19 regulatory axis that promotes BC progression. |
| Confidence score: |
0.7595 |